# A Study to Investigate the Efficacy and Safety of SC0032, a Magnesium Salt Oral Spray, in Adults With Refractory or Unexplained Chronic Cough

> **NCT07690059** · PHASE2 · RECRUITING · sponsor: **Sensory Cloud, Inc.** · enrollment: 60 (estimated)

## Conditions studied

- Refractory Chronic Cough and Unexplained Chronic Cough

## Interventions

- **COMBINATION_PRODUCT:** SC0032
- **DEVICE:** Placebo

## Key facts

- **NCT ID:** NCT07690059
- **Lead sponsor:** Sensory Cloud, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-13
- **Primary completion:** 2027-01
- **Final completion:** 2027-04
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07690059

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07690059, "A Study to Investigate the Efficacy and Safety of SC0032, a Magnesium Salt Oral Spray, in Adults With Refractory or Unexplained Chronic Cough". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07690059. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*